Our Drug Pricing and Market Access team tracks recent developments in healthcare reform, the Medicaid Drug Rebate Program, the 340B Program, Medicare, and state law....more
7/1/2025
/ Centers for Medicare & Medicaid Services (CMS) ,
Drug Pricing ,
Federal Grants ,
Health Care Providers ,
HRSA ,
Inflation Reduction Act (IRA) ,
Medicaid ,
Medicaid Drug Rebate Program ,
Medicare ,
Medicare Part D ,
Most-Favored Nations ,
Pharmaceutical Industry ,
Pharmacies ,
Pharmacy Benefit Manager (PBM) ,
Prescription Drugs ,
Section 340B
State-level oversight of M&A and other strategic transactions involving healthcare is continuing to expand into new markets and impact growth strategies.
The interest and need for healthcare services transactions in the...more
10/18/2024
/ Acquisitions ,
Antitrust Provisions ,
Federal Trade Commission (FTC) ,
Hart-Scott-Rodino Act ,
Health Care Providers ,
Healthcare Facilities ,
Hospital Mergers ,
Hospitals ,
Merger Agreements ,
Merger Controls ,
Mergers
Growing state-level oversight of M&A and other strategic transactions for healthcare provider businesses will impact growth strategies across major markets.
The volume of healthcare services transactions in the United...more
10/9/2023
/ Acquisitions ,
Change of Control ,
Corporate Practice of Medicine ,
Covered Transactions ,
Hart-Scott-Rodino Act ,
Health Care Providers ,
Healthcare Facilities ,
Hospitals ,
Merger Reviews ,
Mergers ,
Physicians ,
Private Equity ,
Public Policy ,
Threshold Requirements